Finolex Industries Limited has informed the Exchange about Appointment of Secretarial Auditors of the Company
FINPIPE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Finolex Industries reported its Q1 FY26 (June 30, 2025) results along with a major leadership transition. Standalone revenue from operations was Rs 1,043.15 crore, down from Rs 1,140.49 crore in Q1 FY25, while profit before exceptional items and tax fell sharply to Rs 126.15 crore from Rs 228.82 crore a year ago, reflecting weak operational performance. The company, however, booked a one-time exceptional gain of Rs 416.99 crore from the transfer of leasehold land rights (about 25.27 acres) in Chinchwad, Pune, which lifted reported profit after tax to Rs 96.93 crore. On the board, current Managing Director Saurabh Dhanorkar will step down on October 25, 2025, on attaining age 70, and will be succeeded by Udipt Agarwal (currently CCO at Alkyl Amines Chemicals) as the new MD effective November 1, 2025, for a five-year term. Rambabu Sanka was appointed as Director – Technical, while Director – Technical Saumya Chakrabarti resigned for personal reasons, and Independent Director Rajesh Rathi also stepped down citing other commitments. M/s. SVD & Associates was appointed as Secretarial Auditor for five years (FY26–FY30), and the 44th AGM is scheduled for September 12, 2025.
The headline numbers look strong only because of a one-time land transfer gain; underlying operations clearly weakened, which is a concern for shareholders. The MD transition is well-telegraphed and orderly, with an external successor bringing chemical-sector experience, though the market may watch execution closely in the coming quarters.